The Potential Role of R4 Regulators of G Protein Signaling (RGS) Proteins in Type 2 Diabetes Mellitus

Xiaohong Zhang1,2, Hongyan Lv3, Juan Mei1,2

  • 1Shandong Collaborative Innovation Center for Diagnosis, Treatment and Behavioral Interventions of Mental Disorders, Institute of Mental Health, Jining Medical University, Jianshe South Road No.45, Rencheng District, Jining 272013, China.

Cells
|December 11, 2022
PubMed

Insights

Regulators of G protein signaling (RGS) proteins, particularly the R4 subfamily, are crucial for managing insulin secretion and resistance. Targeting RGS proteins offers a promising therapeutic strategy for type 2 diabetes mellitus (T2DM).

Area of Science:

  • Biochemistry
  • Endocrinology
  • Pharmacology

Background:

  • Type 2 diabetes mellitus (T2DM) arises from impaired insulin secretion and insulin resistance (IR).
  • G protein-coupled receptors (GPCRs) are key regulators of insulin secretion and IR, making them therapeutic targets.
  • Regulators of G protein signaling (RGS) proteins modulate GPCR signaling by accelerating GTP hydrolysis.

Purpose of the Study:

  • To review the mechanisms of R4 RGS subfamily proteins in insulin secretion and IR.
  • To analyze the therapeutic potential of R4 RGS proteins for T2DM treatment.

Main Methods:

  • Literature review of research on RGS proteins and their role in T2DM.
  • Analysis of RGS protein function as GTPase-activating proteins (GAPs) for Gα proteins.
  • Examination of GPCR signaling pathways involved in insulin regulation.

Main Results:

  • RGS proteins, especially the R4 subfamily, significantly influence the duration and magnitude of cellular responses to GPCR stimulation.
  • R4 RGS proteins play a critical role in regulating both insulin secretion and insulin resistance.
  • Modulating RGS protein activity presents a viable strategy for T2DM management.

Conclusions:

  • The R4 RGS subfamily is integral to the physiological processes underlying T2DM.
  • Targeting R4 RGS proteins holds significant therapeutic promise for developing novel T2DM treatments.
  • Further research into RGS protein mechanisms can unlock new avenues for diabetes therapy.

Related Concept Videos

Activation and Inactivation of G Proteins01:22

Activation and Inactivation of G Proteins

Heterotrimeric G proteins are guanine nucleotide-binding proteins. As the name suggests, heterotrimeric G proteins are composed of three subunits: alpha, beta, and gamma. They remain GDP-bound or GTP-bound inside the cells and switch between inactive/active states. The Gα subunit possesses the nucleotide-binding pocket that binds guanine nucleotides and switches between GDP or GTP-bound states. In contrast, the Gꞵ and Gγ subunits are always bound together with high...
7.4K
G Protein-coupled Receptors01:15

G Protein-coupled Receptors

G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
12.6K
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
4.1K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.6K
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
5.8K
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
2.6K